China Pharma And Distributors Suffer From Essential Drug List System And Price Cuts
This article was originally published in The Pink Sheet Daily
Executive Summary
Morgan Stanley analysts poured cold water on investor hopes in Hong Kong by downgrading pharma and distribution sectors in a July 7 research note.